loader
Please Wait
Applying Filters...
menu
    • menu

    Setid 803beaaa 33f9 48cc 9a95 C2e887e095b4 Applno 202806 Form Capsule Oral Dosage Eq 75mg Base - Drug Product Composition: Dabrafenib Mesylate

    Menu

    Dabrafenib Mesylate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 40,469Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 202806 / DOSAGE - CAPSULE;ORAL - EQ 75MG BASE

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    DABRAFENIB MESYLATE(UNII: B6DC89I63E)
    (DABRAFENIB - UNII:QGP4HA4G1B)     		DABRAFENIB75mg | 50mg

    Inactive Ingredients

    Ingredient Name
    GlaxoSmithKline Inc
    GlaxoSmithKline LLC
    FERRIC OXIDE RED(1K09F3G675)
    HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO)
    MAGNESIUM STEARATE(70097M6I30)
    MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
    SILICON DIOXIDE(ETJ7Z6XBU4)
    TITANIUM DIOXIDE(15FIX9V2JP)